Hypomethylating agent for acute myeloid leukemia, the efficacy and its effect towards mortality rate: Systematic review

被引:0
|
作者
Tandokallo, Felicia [1 ]
Jhoputri, Caroline Fricilia [1 ]
Kosayuz, Sherina [1 ]
Atmaja, William Surya [1 ]
Kurniawan, Andree [2 ]
机构
[1] Pelita Harapan Univ, Fac Med, Tangerang, Indonesia
[2] Pelita Harapan Univ, Dept Internal Med, Fac Med, Tangerang, Indonesia
关键词
D O I
10.1016/j.annonc.2023.09.342
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P12-1
引用
收藏
页码:S1446 / S1446
页数:1
相关论文
共 50 条
  • [1] Hypomethylating agent as first-line treatment for acute myeloid leukemia: Systematic review
    Jhoputri, Caroline Fricilia
    Tandokallo, Felicia
    Kosayuz, Sherina
    Atmaja, William Surya
    Kurniawan, Andree
    ANNALS OF ONCOLOGY, 2023, 34 : S1446 - S1446
  • [2] Efficacy of enasidenib on acute myeloid leukemia: a systematic review
    Fu, R. C. E.
    Sumampow, M. M. A.
    Delvino, D.
    Albert, N.
    Gunawan, P. L.
    ANNALS OF ONCOLOGY, 2024, 35 : S1361 - S1362
  • [3] Evaluation of Infection in Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents: A Systematic Review
    Blankstein, Anna R.
    Sriranjan, Neelan
    Choi, Nora
    Paulson, Kristjan
    Sanford, David
    Mozessohn, Lee
    Houston, Donald S.
    Rimmer, Emily
    Lother, Sylvain
    Mendelson, Asher
    Garland, Allan
    Buckstein, Rena
    Hay, Annette E.
    Zarychanski, Ryan
    Houston, Brett L.
    BLOOD, 2022, 140 : 6092 - 6093
  • [4] Mutational correlates of response to hypomethylating agent therapy in acute myeloid leukemia
    Coombs, Catherine C.
    Sallman, David A.
    Devlin, Sean M.
    Dixit, Shweta
    Mohanty, Abhinita
    Knapp, Kristina
    Al Ali, Najla H.
    Lancet, Jeffrey E.
    List, Alan F.
    Komrokji, Rami S.
    Padron, Eric
    Arcila, Maria E.
    Klimek, Virginia M.
    van den Brink, Marcel R. M.
    Tallman, Martin S.
    Levine, Ross L.
    Rampal, Raajit K.
    Rapaport, Franck
    HAEMATOLOGICA, 2016, 101 (11) : E457 - E460
  • [5] Hypomethylating Agent Maintenance for Favorable and Intermediate Risk Acute Myeloid Leukemia
    Singh, Reema
    Halder, Rohan
    Verma, Megha
    Mehta, Pallavi
    Agrawal, Narendra
    Ahmed, Rayaz
    Bhurani, Dinesh
    BLOOD, 2022, 140 : 11713 - 11715
  • [6] Efficacy and Safety of Selinexor for Acute Myeloid Leukemia: A Systematic Review
    Hashmi, Mydah Sajid
    Sharif, Muhammad Ans
    Jaan, Ali
    Salman, Umer
    Aziz, Summera
    Shahab, Asna
    Ahmed, Zahoor
    Tariq, Muhammad Junaid
    Haider, Mobeen Zaka
    Anwer, Faiz
    BLOOD, 2020, 136
  • [7] Immunomodulatory Effect of SGI-110, a Novel Hypomethylating Agent in Acute Myeloid Leukemia (AML)
    Stroopinsky, Dina
    Pyzer, Athalia Rachel
    Palmer, Kristen A.
    Coll, Maxwell D.
    Bar-Natan, Michal
    Rajabi, Hasan
    Somaiya, Poorvi
    Luptakova, Katarina
    Jain, Salvia
    McMasters, Malgorzata
    Levine, James D.
    Arnason, Jon
    Taverna, Pietro
    Kufe, Donald
    Avigan, David
    Rosenblatt, Jacalyn
    BLOOD, 2014, 124 (21)
  • [8] The efficacy of venetoclax and hypomethylating agents in acute myeloid leukemia with extramedullary involvement
    Otoukesh, Salman
    Zhang, Jianying
    Nakamura, Ryotaro
    Stein, Anthony S.
    Forman, Stephen J.
    Marcucci, Guido
    Pullarkat, Vinod
    Aldoss, Ibrahim
    LEUKEMIA & LYMPHOMA, 2020, 61 (08) : 2020 - 2023
  • [9] Efficacy of hypomethylating agents and Venetoclax in unfit patients with acute myeloid leukemia
    Rieger, M.
    Manz, M. G.
    Muller, R.
    Theocharides, A. P. A.
    Schwotzer, R.
    SWISS MEDICAL WEEKLY, 2020, : 17S - 17S
  • [10] The preclinical efficacy of the novel hypomethylating agent NTX-301 as a monotherapy and in combination with venetoclax in acute myeloid leukemia
    Lim, Byungho
    Yoo, Dabin
    Chun, Younghwa
    Go, Areum
    Cho, Kyung-Jin
    Choi, Daeun
    Jung, Myoung Eun
    Lee, Ha Young
    Boohaker, Rebecca J.
    Lee, Jin Soo
    Jung, DooYoung
    Choi, Gildon
    BLOOD CANCER JOURNAL, 2022, 12 (04)